Transduction of normal and malignant oral epithelium by particle bombardment

E J Shillitoe1, S Noonan, C C Hinkle

  • 1Department of Microbiology and Immunology, State University of New York College of Medicine, Syracuse 13210, USA.

Cancer Gene Therapy
|June 11, 1998
PubMed

Insights

Particle bombardment shows limited success in gene transfer for oral cancer treatment. While it transduced some cells, its efficiency is lower than adenovirus vectors, requiring further improvements for clinical application.

Area of Science:

  • Oncology
  • Gene Therapy
  • Molecular Biology

Background:

  • Genetic approaches for oral cancer treatment are emerging.
  • Effective transduction methods for oral mucosa and early cancers are lacking.
  • Particle bombardment (gene gun) is explored as a potential gene delivery technique.

Purpose of the Study:

  • To evaluate the efficacy of particle bombardment for transducing oral cancer cells in vitro.
  • To assess particle bombardment's ability to transduce normal hamster cheek pouch epithelium in vivo.
  • To compare particle bombardment with lipofection and adenovirus vectors for gene delivery.

Main Methods:

  • Utilized a gene gun to deliver a beta-galactosidase-thymidine kinase (GAL-TEK) fusion gene.
  • Tested gene delivery in oral cancer cells in vitro and hamster cheek pouch epithelium in vivo.
  • Compared transduction efficiency and therapeutic effect with lipofection and adenovirus vectors.

Main Results:

  • Particle bombardment transduced up to 13% of oral cancer cells in vitro, reducing growth by 24.3% with ganciclovir.
  • In vivo, particle bombardment showed beta-galactosidase expression for up to 5 days, but transduced cells were rare and superficial.
  • Adenovirus vector demonstrated higher transduction efficiency (54%) and complete growth inhibition compared to particle bombardment and lipofection.

Conclusions:

  • Particle bombardment shows limited efficiency for transducing oral mucosa and early oral cancers.
  • Current gene gun technology requires significant improvement for effective gene therapy in oral cancer management.
  • Adenovirus vectors appear more promising for oral cancer gene therapy based on this comparative study.